Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-28

Clinical Trial Update: A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating UHE-103 Cream in subjects with Moccasin Type Tinea Pedis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UHE-103 Cream

Snippet

Sponsor: Therapeutics, Inc. | Conditions: Tinea Pedis | Phase 2 | Status: COMPLETED